Treatment of Aortoiliac Embolism with Acute Limb Ischaemia in Infants and Children Younger Than 2 Years

Clinical Scenario

Aortoiliac embolism presenting as acute limb ischaemia in infants and children under 2 years of age represents a distinct clinical situation. This age group requires a specific, age-adapted management strategy.

Treatment Approach

In this age group, initial management centres on conservative systemic anticoagulation. The complete protocol — including agent selection, age-specific parameters, and how monitoring targets are applied — is detailed in the full structured regimen.

Treatment Goal

Response is assessed through coagulation monitoring. Achieving and maintaining the target coagulation range is the primary measure of therapeutic success.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ejvs.2019.09.006

For infants and children younger than 2 years of age with acute limb ischaemia, initial conservative management with heparin is recommended.

Both UFH and LMWH may be used as anticoagulants.

View source ↗